UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050625
Receipt number R000055815
Scientific Title A study of the concentration of povidone-iodine that causes false positive in intradermal test
Date of disclosure of the study information 2023/03/20
Last modified on 2024/03/29 15:08:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of the concentration of povidone-iodine that causes false positive in intradermal test

Acronym

A study of the concentration of povidone-iodine that causes false positive in intradermal test

Scientific Title

A study of the concentration of povidone-iodine that causes false positive in intradermal test

Scientific Title:Acronym

A study of the concentration of povidone-iodine that causes false positive in intradermal test

Region

Japan


Condition

Condition

not applicable

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to study the concentration of povidone-iodine that causes false negative positive in intradermal test

Basic objectives2

Others

Basic objectives -Others

to study the concentration of povidone-iodine that causes false negative positive in intradermal test

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

the diameter of initial wheal just after injection and 20 min post-injection at each concentration of povidone-iodine

Key secondary outcomes

none


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

intradermal test

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

healthy volunteer

Key exclusion criteria

Those who are allergic to ingredients of povidone-iodine
Those who are allergic to alcohol
Those who are taking drugs that may affect intradermal tests, such as steroids and antihistamines
Those who have a history of allergies due to food, medicines, or cosmetics
Those with skin disease currently being treated
Under the age of 18

Target sample size

18


Research contact person

Name of lead principal investigator

1st name Kimitoshi
Middle name
Last name Nishiwaki

Organization

Nagoya University Graduate School of Medicine

Division name

Anesthesiology

Zip code

466-8560

Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2111

Email

nishi@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Yasuhiro
Middle name
Last name Amano

Organization

Nagoya University Hospital

Division name

Anesthesiology

Zip code

466-8560

Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2111

Homepage URL


Email

dj.yasuhige@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Hospital, bioethics committee

Address

65 Tsurumai-cho, Showa-ku, Nagoya

Tel

052-744-2111

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学医学部附属病院(愛知県)


Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

4

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2022 Year 09 Month 22 Day

Date of IRB

2023 Year 02 Month 16 Day

Anticipated trial start date

2023 Year 03 Month 20 Day

Last follow-up date

2024 Year 03 Month 29 Day

Date of closure to data entry

2024 Year 03 Month 29 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 18 Day

Last modified on

2024 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055815


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name